GMRE:NYE-Global Medical REIT Inc (USD)

COMMON STOCK | REIT - Healthcare Facilities |

Last Closing

USD 7.88

Change

+0.06 (+0.77)%

Market Cap

N/A

Volume

0.51M

Analyst Target

USD 14.79
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-11 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

+0.29 (+0.20%)

USD 88.79B
VTR Ventas Inc

-0.19 (-0.32%)

USD 24.71B
DOC Healthpeak Properties Inc

+0.02 (+0.10%)

USD 14.53B
CTRE CareTrust REIT Inc.

-0.36 (-1.38%)

USD 5.04B
AHR American Healthcare REIT, Inc.

-0.88 (-3.09%)

USD 4.42B
NHI National Health Investors Inc

-0.63 (-0.94%)

USD 3.15B
LTC LTC Properties Inc

+0.07 (+0.21%)

USD 1.54B
CHCT Community Healthcare Trust Inc

+0.17 (+0.85%)

USD 0.55B
UHT Universal Health Realty Income..

+0.45 (+1.17%)

USD 0.52B
GMRE-PA Global Medical REIT Inc

-0.02 (-0.08%)

USD 0.41B

ETFs Containing GMRE

KBWY Invesco KBW Premium Yield.. 0.00 % 0.35 %

+0.04 (+0%)

USD 0.22B
SDEF 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.07% 67% D+ 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.07% 67% D+ 48% F
Trailing 12 Months  
Capital Gain -15.18% 14% F 13% F
Dividend Return 9.04% 93% A 91% A-
Total Return -6.14% 14% F 16% F
Trailing 5 Years  
Capital Gain -49.49% 38% F 10% F
Dividend Return 26.54% 69% C- 77% C+
Total Return -22.95% 31% F 15% F
Average Annual (5 Year Horizon)  
Capital Gain -4.76% 36% F 12% F
Dividend Return 1.96% 36% F 31% F
Total Return 6.72% 86% B+ 91% A-
Risk Return Profile  
Volatility (Standard Deviation) 25.13% 43% F 43% F
Risk Adjusted Return 7.80% 36% F 25% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.